PHARMACEUTICAL PREPARATIONS NERVE REGENERATION

Brand Owner Address Description
NERVUSION GELITA HEALTH GMBH Uferstrasse 7 69412 Eberbach Germany Pharmaceutical preparations for nerve regeneration, nerve transplantation, treatment of nerve injuries, symptoms of paralysis, motion disorders, anastomosis and for the regeneration of neural tissues and veterinary preparations for cattle, horses, dogs, cats and pigs for nerve regeneration, nerve transplantation, treatment of nerve injuries, symptoms of paralysis, motion disorders, anastomosis and for the regeneration of neural tissues; medical plasters; materials for medical dressings; preparations for healing wounds, namely, oils, lotions, gels, and ointments for healing nerve damages and for the regeneration of neural tissues; drug delivery agents in the form of resorbable and absorbable material on the basis of gelatine for internal medical application, namely, sponges, tamponades, fleeces and foils for treating nerve diseases and for the regeneration of neural tissues; drug delivery agents in the form of resorbable and absorbable material on the basis of oxidised cellulose for internal medical application, namely, sponges, tamponades, fleeces and foils for treating nerve diseases and for the regeneration of neural tissues; drug delivery agents in the form of resorbable and absorbable material on the basis of collagen for internal medical application, namely, sponges, tamponades, fleeces and foils for treating nerve diseases and for the regeneration of neural tissues; animal and vegetable proteins, fats and oils in solid or liquid form for making pharmaceutical products and as pharmaceutical product for the treatment of nerve diseases and for the regeneration of neural tissues; biodegradable and biocompatible medical products, namely, sponges, tamponades, fleeces and foils containing gelatine for the regeneration of nerve damage, in particular in tubular form; pharmaceutical and veterinary products, namely, biodegradable and biocompatible preparations containing gelatine for the regeneration of nerve damage, in particular in tubular form; biodegradable and biocompatible material containing gelatine, in particular in tubular form, for internal medical application, in particular for the regeneration of nerve damage; pharmaceutical preparations, namely, medicated oils, lotions, gels, or ointments for the relief of symptoms caused by shingles, diabetes, and for treatment of wounds, in solid, liquid or dissolved form; all the afore-mentioned goods in this class not for external application, in particular, not for dermal application;Proteins and products, namely, oils, lotions, gels, sprays or ointments for skin or lip use, namely, body oils, body lotions, hair and shower gels, scented body spray and body cream containing protein in solid, liquid or dissolved form as cosmetic products; preparations, namely, non-medicated topical oils, lotions, gels, or ointments, namely, body oils, body lotions, hair and shower gels, scented body spray, body cream, and general purpose mentholated ointment not for medical use, in solid, liquid or dissolved form as end products for use as cosmetics; medicated soaps; all the aforesaid goods included in this class, in particular containing gelatine, collagen and/or cellulose or made on the basis of gelatine, collagen and/or cellulose;NERVE FUSION;Chemicals used in industry and science; unprocessed plastics; adhesives used in industry; gelatine for industrial purposes; collagen and collagen fibers used as a raw ingredient for industrial purposes; gelatine for industrial purposes; protein as a raw material, namely, gelatine and collagen; proteins for making chemicals and used in the manufacture of cosmetic products, pharmaceutical and medical preparations; gelatine glue, gelatine hydrolyses for technical purposes;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.